EDIT vs PCAR · rev $32.3M vs P/E 25, rev $33.66B
Editas Medicine Inc (EDIT) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
EDIT currently screens at market cap $375.2M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the EDIT and PCAR stock pages for the full models.
Not investment advice.